Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.00 | 19.84 |
| PEG Ratio (TTM) | N/A | 2.50 |
| P/S Ratio (TTM) | 0.00 | 7.74 |
| P/B Ratio (TTM) | 0.00 | 7.79 |
| P/FCF Ratio (TTM) | 0.00 | 39.96 |
| Price to 5YR AVG Earnings Ratio | N/A | 40.45 |
| Price to 5YR AVG FCF Ratio | N/A | 48.59 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -75.91% | 20.29% |
| ROE (TTM) | -98.52% | 29.30% |
| Net Profit Margin (TTM) | -386.06% | 2.03% |
| ROIC 5YR AVG | N/A | 24.57% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 30.89% | 42.41% | N/A |
| Revenue | -7.25% | -12.45% | N/A |
| Net Income | -45.90% | -55.70% | N/A |
| Cash Flow | -5.61% | -167.72% | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.60 | 2.36 |
| Quick Ratio (TTM) | 0.59 | 2.36 |
| D/E Ratio (TTM) | 0.04 | 0.02 |
| Interest Coverage (TTM) | -2.42 | 290.35 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | N/A | 14.05 |
| LTL to 5YR AVG FCF | N/A | 0.64 |
| Shares Outstanding Growth 5YR AVG | N/A | -1.55% |